ConceptMedicine
Biomarker
A measurable biological molecule or indicator used to diagnose a specific disease condition.
Know first
Named as a prerequisite by the lectures that define this. The number is how many say so. A grey one has no page yet.
Biological processes1Disease pathology1Protein expression1Serum analysis1System immunology1Type 1 diabetes1
Opens up
Concepts that name this one as a prerequisite.
Lecturers
2Each in their own terms, from the easiest level.
Sachin Kumar
Erik Gentry
Objective measures of biological characteristics that reflect normal processes, pathogenic processes, or responses to therapeutic interventions.
Lectures that assume it
15The first 12 are shown.
- Dismantling Inequities in Colorectal Cancer Screening and Outcomes (Yale Cancer Center Grand Rounds)
- Biomarkers for Diagnosis of Acute Interstitial Nephritis: From Discovery to Clinical Validation
- The New Role(s) of Surgery After Neoadjuvant Systemic Therapy for Cancer (Yale Cancer Center Grand Rounds)
- Alzheimer's Disease Biomarkers by Dr. Alan Lerner, Case Western Reserve Univ SOM Cleveland Med Ctr
- Making Better Decisions: Using Informatics to Improve Clinical Care
- PHASE I AND PHASE II DESIGNS _ DR MAHESH IYER
- Genome-wide DNA Methylation Profiling in Diagnostics of Central Nervous System Tumors
- Brain Energy Metabolism and Cognitive Decline: Preventing Dementia
- Neurosarcoidosis by David Robertson, MD
- Human Aging: The Immune System Takes The Lead
- PARANEOPLASTIC SYNDROME - DR. JOSH THOMAS GEORGY, MEDICAL ONCOLOGY
- Lecanemab & Donanemab in Early Alzheimer’s Disease by Dr. Robert Friedland & Dr. Michael Sowell
Connections
24The lectures that define it or assume it, and the concepts next to it.
Concepts6
Lectures18
- Immune Basis of Autoimmune Disorders
- Systems Immunology and Immune Monitoring Techniques
- Biomarker-Guided Diagnosis of Alzheimer’s Disease and Common Mimics
- Dismantling Inequities in Colorectal Cancer Screening and Outcomes (Yale Cancer Center Grand Rounds)
- Biomarkers for Diagnosis of Acute Interstitial Nephritis: From Discovery to Clinical Validation
- The New Role(s) of Surgery After Neoadjuvant Systemic Therapy for Cancer (Yale Cancer Center Grand Rounds)
Show 12 moreShow fewer
- Alzheimer's Disease Biomarkers by Dr. Alan Lerner, Case Western Reserve Univ SOM Cleveland Med Ctr
- Making Better Decisions: Using Informatics to Improve Clinical Care
- PHASE I AND PHASE II DESIGNS _ DR MAHESH IYER
- Genome-wide DNA Methylation Profiling in Diagnostics of Central Nervous System Tumors
- Brain Energy Metabolism and Cognitive Decline: Preventing Dementia
- Neurosarcoidosis by David Robertson, MD
- Human Aging: The Immune System Takes The Lead
- PARANEOPLASTIC SYNDROME - DR. JOSH THOMAS GEORGY, MEDICAL ONCOLOGY
- Lecanemab & Donanemab in Early Alzheimer’s Disease by Dr. Robert Friedland & Dr. Michael Sowell
- “Immune-Mediated Myopathies: An Update on Evaluation & Therapies on the Horizon"
- “Huntington Disease: 2025 Update
- RECENT ADVANCES IN TREATMENT OF STAGE I - III LUNG CANCER - DR. ASHISH SINGH, MEDICAL ONCOLOGY